Literature DB >> 31227302

Unrecognized Osteoporosis Is Common in Patients With a Well-Functioning Total Knee Arthroplasty.

James T Bernatz1, Diane C Krueger2, Matthew W Squire1, Richard L Illgen1, Neil C Binkley3, Paul A Anderson1.   

Abstract

BACKGROUND: Peri-prosthetic fractures after total knee arthroplasty (TKA) are associated with poorer outcomes and high costs. We hypothesize that osteoporosis is under-recognized in the TKA population. The purpose of this study is to report osteoporosis prevalence in a healthy cohort of patients with well-functioning TKA and to compare prevalence between males and females.
METHODS: This study is a cross-sectional study of 30 adults (15 males/15 females) aged 59-80 years without known bone health issues who volunteered to undergo routine dual-energy X-ray absorptiometry 2-5 years (average 3.2 ± 0.8) after primary unilateral TKA. These data plus clinical risk factors were used to estimate fracture risk via the Fracture Risk Assessment Tool and skeletal status (normal, osteopenic, osteoporotic) was determined based on the World Health Organization definition. The National Osteoporosis Foundation criteria for treatment were applied to all patients.
RESULTS: Six of 30 (20%) patients had T-score ≤ -2.5. Eighteen of 30 (60%) patients had T-score between -1 and -2.5 and 6 (20%) patients had T-score ≥ -1. Five patients with normal or osteopenic bone mineral density (BMD) had occult vertebral fractures. Eleven of 30 (36.7%) patients met National Osteoporosis Foundation criteria for pharmacologic treatment.
CONCLUSION: The prevalence of occult osteoporosis meeting treatment guidelines after TKA is substantial in this sample (36.7%). BMD and osteoporosis prevalence are similar between men and women. This underappreciated prevalence of osteoporosis may contribute to peri-prosthetic fracture risk. Arthroplasty surgeons and bone health specialists must be aware of post-operative changes in bone density. These data support the further study of post-operative osteoporosis and consideration of routine BMD screening after TKA. LEVEL OF EVIDENCE: III.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone mineral density; osteopenia; osteoporosis; preoperative screening; total knee arthroplasty

Year:  2019        PMID: 31227302     DOI: 10.1016/j.arth.2019.05.041

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Impact of keel saw blade design and thickness on the incidence of tibial plateau fracture and tibial implant-loosening in cementless medial UKR.

Authors:  Lena Keppler; Steffen Klingbeil; Alexander Martin Keppler; Johannes Becker; Christian Fulghum; Björn Michel; Kilian Voigts; Wolfgang Reng
Journal:  BMC Musculoskelet Disord       Date:  2022-06-21       Impact factor: 2.562

Review 2.  Anterior femoral notching ≥ 3 mm is associated with increased risk for supracondylar periprosthetic femoral fracture after total knee arthroplasty: a systematic review and meta-analysis.

Authors:  Dimitrios Stamiris; Nifon K Gkekas; Konstantinos Asteriadis; Stavros Stamiris; Panagiotis Anagnostis; Lazaros Poultsides; Ioannis Sarris; Michael Potoupnis; Eustathios Kenanidis; Eleftherios Tsiridis
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-04-26

3.  [Progress of change in bone mineral density after knee arthroplasty].

Authors:  Wenxing Wei; Yuangang Wu; Yi Zeng; Bin Shen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

4.  Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty.

Authors:  Yuzhang Tao; Siying Tang; Xiao Huang; Hongwei Wang; Aiguo Zhou; Jian Zhang
Journal:  Clin Interv Aging       Date:  2021-02-26       Impact factor: 4.458

5.  The association between bone mineral density and postoperative drainage volume following cruciate-substituting primary total knee arthroplasty: a cross-sectional study.

Authors:  Yuthasak Peerakul; Jirapong Leeyaphan; Karn Rojjananukulpong
Journal:  Knee Surg Relat Res       Date:  2021-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.